LETTER
Synthetic Analogs of the Lewisb-Tetrasaccharide
1333
which was de-O-acetylated to give the diol 22. Fucosyla-
tion of 22 using 11 and tetraethylammonium bromide
gave 23 in 72% yield. Hydrolysis of the ketal followed by
debenzylation generated the desired compound 315 in 64%
yield (mixture of two isomers 3a and 3b).
Acknowledgement
We thank Dr. A. Otter for carrying out the high-field NMR spectral
analysis, Dr. S. Nilar for the molecular modeling studies, Dr. J.
Sadowska for the ELISA assays and Dr. A. Morales for mass spec-
trometric characterization. This work was supported by grants from
the Natural Sciences and Engineering Research Council of Canada
(NSERC). We are indebted to Professor Thomas Norberg of the
Swedish Agricultural University for his critical review of this
manuscript.
The binding of GS IV to compounds 1–3 and to the parent
compound Leb-OMe was studied by ELISA inhibition as
described in the preceding communication.8 The results
are summarized in Scheme 4. The IC50 of the reference
compound Leb-OMe was 36 mM. All of the three synthe-
sized analogs 1–3 poorly inhibited lectin binding com-
pared to the parent compound, Leb-OMe. The poorest
inhibitor was analog 1, for which no inhibition could be
observed at the concentrations used. Since 1 has the most
flexible linkage between the galactosyl and fucosyl resi-
dues (b and c), this shows the importance of a more con-
formationally rigid linkage between these residues.
However, even though analogs 2 and 3 both have this
more rigid linkage, they were still poor inhibitors com-
pared to Leb-OMe. However, even the analog 2 where Fuc
and Gal residues can adopt similar if not identical relative
orientations on a more rigid template results in a 6-fold
decrease in potency. Hydration of the complex is not like-
ly the reason, since the more hydrophilic 3 was 3-fold
worse again.
References
(1) Varki, A. Glycobiology 1993, 3, 97.
(2) Weis, W. I.; Drickamer, K.; Hendrickson, W. A. Nature
(London) 1992, 360, 127.
(3) Dennis, J. W. In Cell Surface Carbohydrates and Cell
Development; Fukuda, M., Ed.; CRC Press: Boca Raton,
1992, 161–194.
(4) Giannis, A. Angew. Chem., Int. Ed. Engl. 1994, 33, 178.
(5) Karlsson, K. A. Trends in Pharmacol. Sci. 1991, 12, 265.
(6) Lemieux, R. U. Am. Chem. Soc. Sym. Ser. 1993, 519, 5.
(7) Delbaere, L. T. J.; Vadonselaar, M. P. L.; Quail, J. W.;
Wilson, K. S.; Dauter, Z. J. Mol. Chem. 1993, 230, 950.
(8) Kamath, V.; Sadowska, J.; Nilar, S.; Bundle, D. R.;
Hindsgaul, O. Synlett 2003, 1327.
(9) Spohr, U.; Hindsgaul, O.; Lemieux, R. U. Can. J. Chem.
1985, 63, 2644.
(10) Spohr, U.; Lemieux, R. U. Carbohydr. Res. 1988, 174, 211.
(11) Nikrad, P. V.; Beierbeck, H.; Lemieux, R. U. Can. J. Chem.
1992, 70, 241.
(12) Lemieux, R. U. Chem. Soc. Rev. 1989, 18, 347.
(13) Delbaere, L. T. J.; Vandonselaar, M. P. L.; Quail, J. W.;
Nikrad, P. V.; Pearlstone, J. R.; Carpenter, M. R.; Smillie, L.
B.; Spohr, U.; Lemieux, R. U. Can. J. Chem. 1990, 68, 1116.
(14) Huang, H.; Wong, C.-H. J. Org. Chem. 1995, 60, 3100.
(15) 1H NMR (D2O): 1. d: 4.09 (q, 1 H, H-5b), 4.31 (q, 1 H, H-
5c), 4.57 (d, 1 H, H-1a), 4.93 (d, 1 H, H-1b), 5.23 (d, 1 H, H-
1c); 2. d: 4.48 (q, 1 H, H-5d), 4.56 (d, 1 H, H-1b), 4.70 (q, 1
H, H-5c), 4.99 (d, 1 H, H-1c), 5.28 (d, 1 H, H-1d); 3a. d: 4.35
(d, 1 H, H-5d), 4.52 (d, 1 H, H-1b), 4.60 (q, 1 H, H-5c), 5.00
(d, 1 H, H-1c), 5.28 (d, 1 H, H-1d); 3b. d: 4.57 (d, 1 H, H-
1b), 4.73 (q, 1 H, H-5c), 4.91 (d, 1 H, H-1c), 5.27 (d, 1 H, H-
1d).
Clearly, replacement of the 3,4-disubsituted GlcNAc res-
idue in the Leb tetrasaccahride by a flexible ethane diol as
in 1 can be expected to result in a dramatic decrease in ac-
tivity. However, when this identical strategy was applied
to the development of inhibitors of E-selectin binding to
the tetrasaccharide sialyl-LeX (SLeX), replacement of a
3,4-diglycosylated GlcNAc residue by ethane diol yielded
a greatly simplified structure that was as potent as the
parent compound.14 Replacement of the same GlcNAc
residue in SLeX by cyclohexane diol (as was done for 2)
yielded a structure that was almost an order of magnitude
more active.17 In conclusion, and as expounded by
Lemieux,12 the binding of oligosaccharides by proteins re-
mains poorly understood and rules for the design of potent
inhibitors are in the early stages of development. One of
the most important and difficult factors to incorporate into
inhibitor design is the difference in hydration of the free
protein and sugar vs the complex they form on binding.
(16) Suemune, H.; Hizuka, M.; Kamashita, T.; Sakai, K. Chem.
Pharm. Bull. 1989, 37, 1379.
(17) Banteli, R.; Ernst, B. Tetrahedron Lett. 1997, 38, 4059.
HO
HO
HO
HO
OH
OH
OH
OH
OH
OH
c
OH
OH
O
O
O
O
OH
HO
HO
OH
HO
HO
HO
HO
HO
OH
OH
OH
O
OH
O
O
O
O
O
O
a
O
O
O
O
b
O
O
OMe
O
OH
NHAc
O
O
O
OH
O
O
d
O
O
OH
OH
OH
OH
OH
OH
OH
OH
HO
HO
HO
HO
3; IC50 = 730 µM
Leb-OMe; IC50 = 36 µM
2; IC50 = 222 µM
1; IC50 = inactive
Scheme 4
Synlett 2003, No. 9, 1331–1333 ISSN 1234-567-89 © Thieme Stuttgart · New York